RxDoctor Payments DataLook up a doctor →

Richmond McCarty, DO

General Practice · Saltillo, MSNPI 1487632188

Payments from drug & device makers

$6,048in general payments, 2019–2025

Across 396 payments — averaging $15.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$857
  • GSK$727
  • Novo Nordisk$712
  • Boehringer Ingelheim$615
  • Lilly USA, LLC$431
  • AstraZeneca$401
  • plus $2K from 33 others

What the payments were for

  • Food & beverage$6,048100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,048 in reported general payments places this provider in the 95th percentile of 674 general practice providers in Mississippi.

See all general practice providers in Mississippi

Medicare billing

Part B allowed, 2024
$335,496
Medicare patients
699
Services billed
7,757

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide175$214,902
EliquisApixaban186$131,416
JardianceEmpagliflozin96$80,528
Trelegy ElliptaFluticasone/Umeclidin/Vilanter50$38,810
Breztri AerosphereBudesonide/Glycopyr/Formoterol53$34,417
FarxigaDapagliflozin Propanediol32$32,968
MounjaroTirzepatide31$29,885
Tresiba Flextouch U-200Insulin Degludec48$29,806
TrulicityDulaglutide18$26,908
Xigduo XrDapaglifloz Propaned/Metformin30$22,274
Repatha SureclickEvolocumab18$21,651
Tresiba Flextouch U-100Insulin Degludec33$20,255
MyrbetriqMirabegron19$18,523
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr41$18,239
GlyxambiEmpagliflozin/Linagliptin22$13,817

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$712$214,902175 claims
PfizerEliquis$237$131,416186 claims
Boehringer IngelheimJardiance, Glyxambi$615$94,345118 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Incruse Ellipta$727$71,820118 claims
AstraZenecaBreztri Aerosphere, Farxiga$401$67,38585 claims
Lilly USA, LLCMounjaro, Trulicity$431$56,79349 claims
AbbVieLinzess, Synthroid$857$13,34457 claims
Johnson & JohnsonInvokamet$40$6,74912 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$130$6,08611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 674 general practice providers in Mississippi.

Other general practice in Saltillo

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →